In autosomal dominant polycystic kidney disease (ADPKD), cyst formation and enlargement require proliferation of mural renal epithelial cells and the transepithelial secretion of fluid into the cyst cavity. Na,K-ATPase is essential for solute and water transport in ADPKD cells, and ouabain blocks fluid secretion in these cells. By binding to the Na,K-ATPase, ouabain also induces proliferation in some cell types. Surprisingly, it was found that nanomolar concentrations of ouabain, similar to those circulating in blood, induced ADPKD cell proliferation but had no statistically significant effect on normal human kidney (NHK) cells. Ouabain, acting from the basolateral side of the cells, also caused an increase in the level of phosphorylated extracellular signal-regulated kinases (ERK). Mitogen-activated protein kinase kinase (MEK) inhibitor U0126 blocked ouabain-induced ERK activation and cell proliferation, suggesting that ouabain effect is mediated through the MEK-ERK pathway. In contrast to NHK cells, the dose-response curve for ouabain inhibition of Na,K-ATPase activity indicated that approximately 20% of the enzyme in ADPKD cells exhibits a higher affinity for ouabain. The increased ouabain affinity of ADPKD cells was not due to differences in Na,K-ATPase isoform expression because these cells, like NHK cells, possess only the ␣1 and ␤1 subunits. The ␥ variants of the Na,K-ATPase also are expressed in the cells but are elevated in ADPKD cells. Currently, the basis for the differences in ouabain sensitivity of NHK and ADPKD cells is unknown. It is concluded that ouabain stimulates proliferation in ADPKD cells by binding to the Na,K-ATPase with high affinity and via activation of the MEK-ERK pathway.
T he Na,K-ATPase is an enzyme of the plasma membrane of most cells that uses cellular ATP to exchange cytoplasmic Na ϩ for extracellular K ϩ (1) . The function of the Na,K-ATPase is essential for the generation and maintenance of the electrochemical gradients that drive the secondary movement of solute and fluid across renal epithelia (2) . Structurally, the Na,K-ATPase is an oligomer that is composed of distinct molecular forms of two major polypeptides, the ␣ and ␤ subunits (3) . At present, four structural variants of the ␣ polypeptide (␣1, ␣2, ␣3, and ␣4) and three ␤ (␤1, ␤2, and ␤3) subunits have been identified in mammals. Association of the ␣ and ␤ polypeptides in different oligomers results in multiple isozymes of the Na,K-ATPase that have unique functional properties and a tissue-specific pattern of expression (3) . The ␣1 and ␤1 isoforms constitute the Na,K-ATPase isozyme that is expressed ubiquitously in tissues and the prevalent isozyme in kidney (2) (3) (4) . In addition to the ␣ and the ␤ subunits, the renal Na,K-ATPase contains a third subunit, the ␥ polypeptide, that exists as two different splice variants, ␥a and ␥b (5).
Cardiotonic steroids comprise a family of compounds that bind to the ␣ subunit of the Na,K-ATPase to inhibit the function of the enzyme. These compounds are used clinically to increase heart contraction and cardiac output in patients with heart failure (6,7). Ouabain, a cardiotonic steroid, has been shown to be an endogenous factor that is secreted by the adrenal glands in humans and other mammals and is present in blood at nanomolar concentrations (8) . The mechanisms of action of ouabain have been attributed classically to ion changes that are secondary to inhibition of the catalytic and transport activity of the Na,K-ATPase (6) .
More recently, it was shown that ouabain also induces proliferation of several cell types, including myocardial cells, smooth muscle cells, astrocytes, and renal proximal tubule cells (9 -14) . The mechanisms for the mitogenic effect of ouabain are not completely understood. In myocardial cells, binding of ouabain to the Na,K-ATPase activates Src kinase and tyrosine phosphorylation of proteins, including the EGF receptor. Transactivation of EGF receptor then leads to a cascade of phosphorylating events that include the mitogen-activated protein kinase kinase (MEK) and extracellular signal-regulated kinases (ERK) (15) . Activation of the MEK-ERK pathway results in expression of genes that are involved in cell growth (15) .
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation and progressive enlargement of cysts in the kidney that disrupt the structure and severely compromise renal function in approximately half of the patients (16, 17) . In ADPKD, mutations of at least two genes, PKD1 and PKD2, which encode for polycystin 1 and 2, respectively, initiate cyst formation. However, the progressive enlargement of cysts seems to be regulated by a variety of factors, including growth hormones and cAMP agonists (18 -20) . Arginine vasopressin (AVP) and EGF stimulate cell proliferation of human ADPKD cells through activation of the MEK-ERK pathway (21) (22) (23) (24) . cAMP causes cell proliferation in human cells and animal models of PKD, also via the MEK-ERK pathway, through B-Raf, a kinase that phosphorylates and activates MEK (25, 26) . In addition, cyst expansion is the result of transepithelial fluid secretion that is driven by the cAMP-dependent secretion of Cl Ϫ (27) . Because of its central role in salt and water transport, the Na,K-ATPase has been the focus of investigation to understand the pathophysiology of PKD (17) . Addition of relatively high concentrations of ouabain to basolateral but not apical membranes of ADPKD cell monolayers (28) and intact cysts that were dissected from ADPKD kidneys (29) were shown to inhibit fluid secretion. However, the effect of low concentrations of ouabain, similar to those circulating in blood, on renal cyst growth has not been examined. In this study, we investigated the effect of physiologic concentrations of ouabain on the growth and MEK-ERK pathway of cells that were derived from normal human kidneys and from renal cysts of patients with ADPKD. This is the first report to demonstrate that human ADPKD cells present an abnormally high sensitivity to ouabain and that the steroid stimulates proliferation of ADPKD cells at a higher rate than normal human kidney (NHK) cells via activation of the MEK-ERK pathway.
Materials and Methods

Cell Culture
Primary cell cultures that were derived from nephrectomy specimens of NHK cells or surface cysts of ADPKD kidneys (ADPKD cells) were generated by the PKD Biomaterial Core at University of Kansas Medical Center (KUMC). A protocol for the use of discarded human kidney tissues was approved by the institutional review board at KUMC. Primary cultures were prepared as described previously (30) . Cells were seeded and grown in DMEM/F12 supplemented with 5% heatinactivated FBS, 100 IU/ml penicillin G and 0.1 mg/ml streptomycin, 5 g/ml insulin, 5 g/ml transferrin, and 5 ng/ml sodium selenite (ITS). Cells were cultured on both filter supports (Transwell Costar, Corning, NY) and plastic culture dishes. When the cells were grown to confluence on filter supports, cell polarity of the cultures was confirmed by the achievement of a transepithelial electrical resistance by the cell monolayer, measured with an EVOM volt ohmmeter (World Precision Instruments, Sarasota, FL) as described previously (31) . In culture, both ADPKD and NHK cells are able to establish a monolayer, form tight junctional complexes, and develop a transepithelial electrical potential difference, and they carry out an active transepithelial transport of salt and fluid (27, 30, 32) . As previously shown, these cells are epithelial in nature, and the majority of the cells stain positive for specific lectin markers for the collecting duct and distal nephron, such as Arachis hypogaea and Dolichos biflorus agglutinin (26) . Altogether, this suggests that both cell types are enriched in cells that are derived from distal nephrons and collecting tubules. In agreement with this observation, aquaporin-2, a marker for collecting tubules, was detected by immunoblot analysis in both NHK and ADPKD cells (Figure 1 ).
Biochemical Assays
Protein assays were performed using the dye-binding assay from Bio-Rad (Hercules, CA). Na,K-ATPase activity was determined on homogenates of NHK and ADPKD cells that were grown to confluence on filter supports or plastic dishes. Specific ATP hydrolysis was determined by measurement of the initial rate of release of 32 
Reverse Transcriptase-PCR Analysis
Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA). cDNA was generated by reverse transcription using the SuperScript First-Strand Synthesis System (Invitrogen) and oligo (dT) primers as described previously (33) . The resulting first-strand cDNA was amplified using Na,K-ATPase isoform specific primers and under PCR conditions that ensure no cross-reactivity among the Na,K-ATPase isoforms. The sequences of the primers used and their annealing properties and the size of the amplified cDNA are described in Table 1 . The amplified DNA fragments were identified by electrophoresis in a 1% agarose gel that was stained with ethidium bromide.
Immunoblot Analysis of Na,K-ATPase Isoforms
Cell proteins (30 g) from homogenates of NHK and ADPKD cells that were grown to confluence on filter supports or plastic were analyzed by 8% SDS-PAGE for the ␣ and ␤ isoforms or 16% tricine gels for the ␥ subunit and blotted onto nitrocellulose membranes (Osmonics, Minnetonka, MN) as described (33, 34) . Primary antibodies that are specific for each Na,K-ATPase isoform were incubated overnight at 4°C. Horseradish peroxidase-conjugated secondary antibodies and chemiluminescence were used for detection.
Measurement of Cell Proliferation
NHK and ADPKD cells (4000 cells/well) were seeded onto a 96-well plate with culture medium supplemented with 1% FBS and ITS. After 24 h, ITS was removed and the serum concentration was reduced to Figure 1 . Expression of aquaporin-2 in normal human kidney (NHK) and autosomal dominant polycystic kidney disease (ADPKD) cells. Proteins from normal and cystic cell homogenates were separated by SDS-PAGE, transferred to nitrocellulose, and immunoblotted using an anti-aquaporin-2 antibody. A horseradish peroxidase-conjugated secondary antibody and chemiluminescence were used for detection. 0.002%. After an additional 24 h, the cells were treated with control medium or with various concentrations of ouabain for 24 h. Cell proliferation was determined using the Promega CellTiter 96 MTT Assay according to the manufacturer's recommendations (Promega, Madison, WI). This method is based on the metabolism of a tetrazolium salt by the cells, and the optical density of the formazan product formed is proportional to the metabolic activity and the number of cells in the culture (35) . Proliferation rates also were determined by counting cells with a hemocytometer. In all proliferation assays, data are presented as a percentage of proliferation of untreated cells. 
Measurement of Cell Mitosis
Immunoblot Analysis of Phosphorylated ERK Levels
NHK and ADPKD cells (1 ϫ 10 5 ) were grown in six-well plates under the same conditions as described previously and then treated with varying ouabain concentrations for 0, 15, 30, 60, 90, and 120 min. In some experiments, ouabain was added to either the apical or basolateral side of ADPKD cell monolayers that were grown on filter supports to determine whether the ouabain-induced ERK activation was unique to one membrane domain. In all cases, cells were washed with ice-cold PBS and lysed with 1% NP-40, 0.25% sodium deoxycholate, 1 mM NaVO 3 , 1 mM NaF, 150 mM NaCl, 1 mM EDTA, 50 mM Tris, and protease inhibitor cocktail (Sigma, St. Louis, MO). The cleared lysates (15 g of total protein) were analyzed by 10% SDS-PAGE and blotted onto nitrocellulose membranes. The immunoblots first were analyzed for levels of phosphorylated ERK, and then the membranes were stripped and probed for total ERK, using antibodies from Santa Cruz Biotechnology (Santa Cruz, CA). After detection by chemiluminescence, the images were scanned and quantified for band intensity using the Gel-Pro software (Media Cybernetics, Silver Spring, MD). Levels of phosphorylated ERK (P-ERK) and total ERK were expressed as density units relative to the untreated controls, and presented as P-ERK to total ERK ratios.
Immunocytochemistry of Na,K-ATPase in NHK and ADPKD Cells
Cells were grown on filter supports until they were confluent, confirmed by the development of transepithelial electrical resistance. Cells were fixed in 100% methanol for 45 min at Ϫ20°C and were subjected to immunocytochemistry as described previously (31) . An anti-␣1 mAb (6F; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) was used, followed by an Alexa Fluor 594 -conjugated secondary antibody (Molecular Probes). Slides were analyzed using a Zeiss LSM510 confocal microscope. Images were acquired in Multitrack channel mode with LSM510 (v 3.2) software and a Plan-Apochromat 63ϫ/1.4 Oil DIC objective (Carl Zeiss Microimaging) with a frame size of 1024 ϫ 1024 pixels and a zoom factor of 2. Z-line views were obtained by averaging 10 sections over a line at each z position in 1.0-m steps.
Statistical Analyses
Curve fitting of the experimental points was performed using a Marquardt least-squares nonlinear regression computing program (Sigma Plot; Jandel Scientific, San Rafael, CA). Dose-response relations for the ouabain inhibition of Na,K-ATPase activity were fitted by Table 1 . Characteristics of the primers that were used for RT-PCR analysis of Na,K-ATPase isoforms in normal and cystic human kidney epithelial cells equations assuming the presence of one or two enzyme populations with different affinity for ouabain as described previously (33) . The validity of using a two versus a single component regression model for ouabain binding was statistically supported by applying the Snedecor F test (36) . Statistical significance of the differences between ouabaintreated and untreated controls was determined by ANOVA, whereas differences between normal and cystic cells were analyzed by t test. Statistical significance was defined as P Ͻ 0.05.
Results
Effect of Ouabain on Proliferation of NHK and ADPKD Cells
Ouabain binding to the Na,K-ATPase causes induction of various transcription factors and upregulation of genes that are involved in cell growth (15) . To determine whether ouabain affects the proliferation of NHK and ADPKD cells, we measured the rate of cell proliferation in the presence of various concentrations of ouabain using a proliferation assay. Surprisingly, concentrations of ouabain as low as 10 Ϫ10 M and in the nanomolar range (1 ϫ 10 Ϫ10 to 3 ϫ 10 Ϫ8 M) significantly increased the rate of proliferation of ADPKD cells (30 to 40%) compared with ADPKD cells in control medium (Figure 2A ). Concentrations below 10 Ϫ10 M had no significant effect, whereas concentrations at 10 Ϫ7 M and higher instead inhibited cell proliferation, corresponding with extensive inhibition of Na,K-ATPase activity (4). In contrast, nanomolar ouabain concentrations did not have a statistically significant effect on the proliferation of NHK cells. The ouabain effect on cell proliferation also was determined by direct cell count using a hemocytometer ( Figure 2B ). These data confirm that ouabain increased the proliferation of ADPKD cells in a dose-dependent manner but had no significant effect on the growth of NHK cells. The same results were obtained when the NHK cells were grown at a lower cell density (data not shown), suggesting that the lack of effect of ouabain on cell proliferation was not due to the extent of cell confluence but rather depended on the particular response of the cells to the steroid.
To examine further the effect of ouabain on cell proliferation, we measured the number of mitotic cells in cultures of NHK and ADPKD cells 1, 3, 5, 8, and 24 h after treatment with 3 ϫ 10 Ϫ9 M ouabain ( Figure 3 ). Phosphorylation of histone H3 is a commonly used marker for cell division (14) , which correlates with the chromosomal condensation that accompanies the onset of mitosis. Treatment with ouabain for 1 h increased the number of ADPKD cells that stained positive for phosphohistone H3 (percentage of total cell number) approximately two-fold compared with the untreated cells. The mitotic index (percentage of phospho-histone H3-positive cells) for ADPKD cells that were treated with ouabain increased three-fold at 3 h and remained elevated throughout the 24-h incubation period ( Figure 3B ). In contrast, ouabain caused only a small increase in the mitosis of NHK cells at 3 h of incubation, with no significant difference between the ouabain-treated and control groups at other time points ( Figure 3A) . Altogether, these results demonstrate that nanomolar concentrations of ouabain promote the proliferation of human ADPKD cells that are grown in culture.
Effect of Ouabain on ERK Activity in NHK and ADPKD Cells
In several cell types, ouabain has been shown to stimulate cell growth through activation of the MEK-ERK pathway (15) . To determine whether these mediators are involved in the ouabain-induced proliferation of ADPKD cells, we measured the levels of P-ERK in the cells after treatment with various concentrations of ouabain for various times, from 0 to 120 min.
The effect of 3 ϫ 10 Ϫ9 M ouabain on P-ERK to total ERK ratios for NHK and ADPKD cells is presented in Figure 4 , A and B. Consistent with the lack of an effect of ouabain on cell proliferation, ouabain did not alter significantly ERK activity in NHK cells ( Figure 4A ). In contrast, ouabain increased P-ERK levels in ADPKD cells within 15 min after treatment with the steroid ( Figure 4B ). ERK phosphorylation remained elevated during the subsequent 60-min incubation, and, although levels were slightly lower, significant amounts of P-ERK still were observed by 120 min. There was no change in P-ERK levels in ADPKD cells that were incubated with control medium with- and P-ERK increased at ouabain concentrations between 1 ϫ 10 Ϫ9 and 3 ϫ 10 Ϫ8 M. In contrast, higher ouabain amounts (10 Ϫ7 M), which are known to block significantly Na,K-ATPase activity, failed to elevate P-ERK levels ( Figure 4C ). Altogether, these results suggest that ouabain-induced ADPKD cell proliferation is mediated via ERK activation, and this response occurs within minutes of the addition of nanomolar concentrations of the steroid. To determine whether ERK activation by ouabain occurs from the apical or basal side of the ADPKD cells, we determined levels of P-ERK in confluent cultures that were grown on filter supports. Apical application of ouabain had no effect on P-ERK levels. In contrast, application of ouabain to the basal compartment of the culture chamber caused activation of ERK ( Figure 5A ). In addition, as was observed in the subconfluent cultures ( Figures 2 through 4) , the NHK monolayer that was grown on filter support did not show ERK activation after treatment with ouabain when the steroid was applied from either the apical or the basolateral surface of the cells ( Figure  5B ). In agreement with the effect of ouabain that occurs through the Na,K-ATPase in ADPKD cells, immunocytochemical analyses of the ␣1 isoform of the enzyme showed it to be restricted to the basolateral membrane domain of the ADPKD cells, a distribution that is similar to that of the NHK cells ( Figure 5C ). These results suggest that ouabain acts from the serosal side of ADPKD cells and are in agreement with the notion that ERK activation is mediated by the Na,K-ATPase that is restricted to the basolateral membrane of the cells.
To confirm that the MEK-ERK pathway is central for ouabain-induced proliferation of ADPKD cells, we compared the effect of ouabain in the absence and presence of the MEK inhibitor U0126. We found that 1 M U0126 completely blocked the ouabain-induced proliferation of ADPKD cells ( Figure 6A ). Accordingly, U0126 prevented the phosphorylation of ERK that was caused by ouabain ( Figure 6B ). Also, U0126 decreased ADPKD cell proliferation to levels that were lower than in untreated controls. This suggests an important role of the MEK-ERK pathway in the growth of ADPKD cells. More important, the ability of U0126 to counteract the effects of ouabain strongly suggests that ouabain-induced proliferation in ADPKD cells is mediated through activation of MEK-ERK and not through another pathway.
Ouabain Sensitivity of Na,K-ATPase in NHK and ADPKD Cells
To determine whether the difference in the proliferative response of NHK and ADPKD cells to ouabain was due to differences in the affinity of the Na,K-ATPase to the steroid, we examined the ouabain kinetic response of the Na,K-ATPase of NHK and ADPKD cells. For this, dose-response curves for the inhibition of Na,K-ATPase activity by ouabain were determined ( Figure 7) . NHK cells exhibited a monophasic ouabain inhibition profile ( Figure 7A ), with a ouabain K i of 0.48 Ϯ 0.05 ϫ 10 Ϫ6 M, consistent with what has been described in normal kidney (3, 4, 37) . In contrast, ADPKD cells showed a heterogeneous response, with two Na,K-ATPase populations with different affinities for ouabain. Approximately 80% of the total Na,K-ATPase had a K i for ouabain (1.3 Ϯ 2.0 ϫ 10 Ϫ6 M) similar to that of NHK cells. Surprisingly, the remaining 20% of the enzyme showed a sensitivity for ouabain that was three orders of magnitude higher, with a K i of 1.7 Ϯ 4.7 ϫ 10 Ϫ9 M ( Figure 7B ). The finding that an important fraction of Na,KATPase that is expressed in ADPKD cells has a high affinity for ouabain suggests that the enzyme would be more susceptible to binding the steroid at nanomolar concentrations such as those found in plasma.
Na,K-ATPase Isoform Expression in NHK and ADPKD Cells
Generally, heterogeneous response to ouabain reflects the expression of different isozymes of the Na,K-ATPase (3). Normal kidney expresses predominantly one isozyme of the Na,KATPase, composed of ␣1 and ␤1 isoforms (3, 4) . In our study, the K i for the more resistant Na,K-ATPase component that was observed in both the NHK and ADPKD cells is consistent with the ouabain kinetics that correspond to the ␣1␤1 isozyme (37) . The high ouabain-sensitive Na,K-ATPase that is unique to the cystic cells suggested the presence of additional ␣ or ␤ isoforms. To explore the expression pattern of the Na,K-ATPase ␣ and ␤ isoforms in the kidney cells at the RNA level, we used reverse transcriptase-PCR (RT-PCR) with the primer sets described in Table 1 . Figure 8 , A and C, shows that cDNA for only the ␣1 and ␤1 isoforms were amplified from the normal and ADPKD cells. This agrees with previous results showing that only the ␣1␤1 isozyme is present in kidneys (3). The specificity of the Na,K-ATPase primers used was confirmed by the lack of cross-reactivity with cDNA of ␣ isoforms other than those that contain the corresponding complementary sequence. In addition, PCR reactions that were performed in the absence of reverse transcription yielded no Na,K-ATPase isoform products, indicating the lack of genomic DNA contamination in the RNA isolation step (data not shown).
To determine the expression of the Na,K-ATPase isoforms at the protein level, we performed immunoblot analysis of kidney cell total proteins using antibodies that are specific for the ␣ and ␤ isoforms. In agreement with the RT-PCR analysis, the protein profile of Na,K-ATPase subunits demonstrated that only the ␣1 and ␤1 isoforms were present in NHK and ADPKD cells (Figure 8, B and D) . The ␣2, ␣3, ␣4, ␤2, and ␤3 isoforms were absent and were observed only in human brain and testis (used as positive controls), which express different combinations of the Na,K-ATPase isoforms (Figure 8, A through D, first lane) .
In addition, RT-PCR and immunoblot analysis were performed for the Na,K-ATPase ␥ subunit (Figure 8, E and F) . This showed that both ␥a and ␥b variants of the enzyme are expressed in the cells. It is interesting that relative to the ubiquitously expressed glyceraldehyde-3-phosphate dehydrogenase, the levels of ␥ expression were higher in ADPKD than in NHK cells, both at the RNA and the protein levels. On the basis of the RT-PCR and immunoblot analysis, we conclude that NHK and ADPKD cells present similar Na,K-ATPase isozyme expression profiles and that the ␥ variants of the enzyme are upregulated in ADPKD cells.
Discussion
Our results demonstrate that epithelial cells that are derived from renal cysts of patients with ADPKD have an abnormal mitogenic response to nanomolar concentrations of ouabain. This was reflected by an increase in cell proliferation as detected by the MTT assay, by an enhanced mitotic index, and by an increase in cell number. These findings provide new evidence that ouabain binding to the Na,K-ATPase not only modulates the ion transport of the enzyme but also induces growth signals in cells (15) . The proliferative action of ouabain is apparent in ADPKD cells, and NHK cells are not significantly affected by the steroid. The NHK and ADPKD cells that were used in this study seem to have been derived largely from distal Figure 5 . Effect of apical and basolateral ouabain on ERK activation in polarized ADPKD and NHK monolayers. Activation of ERK was determined in confluent polarized ADPKD (A) and NHK (B) cells after treatment with 3 ϫ 10 Ϫ9 M ouabain for 30 min. Ouabain was applied to either the apical or the basolateral side of the culture. In the controls, the medium from the apical or basolateral side of the culture chambers also was replaced with medium that lacked ouabain. Cells then were lysed, and cellular proteins were subjected to immunoblot for determination of the total and phosphorylated forms of ERK. A representative immunoblot is shown. Values are P-ERK/total ERK, relative to the untreated controls. Bars indicate the means Ϯ SE of six determinations that were performed on three different kidneys for ADPKD cells and four determinations that were performed on two different kidneys for NHK cells. *P Ͻ 0.001 versus the respective control without ouabain. (C) Immunocytochemical analysis of Na,K-ATPase expression in NHK and ADPKD cells. Cells were fixed and the Na,K-ATPase ␣1 isoform was detected by immunofluorescence using a monoclonal 6F antibody. Alexa Fluor 594 -conjugated goat anti-mouse antiserum was used as the secondary antibody. DAPI was included to stain the nuclei. Top panels show z-line views positioned at the lines indicated in the x-y views shown in the bottom panels. ap, apical; bl, basolateral side of the cells.
convoluted and collecting tubules, on the basis of lectin markers and the existence of transport mechanisms that were expressed in those nephron segments (26, 30, 32) (Figure 1) . The similar origin of the cells suggests that the changes in ouabain response that were observed are a consequence of the cellular phenotype of normal renal epithelial cells versus mural cystic cells and not due to differences in the progenitor cell type. The proliferative effects of ouabain have been described in various cell types, including normal proximal tubule cells of the rat kidney (14, 38) . Although we could not detect statistically significant differences in the NHK cells, we observed a trend for an increase in ouabain-dependent proliferation in these cells. . Dose-response curves for the ouabain inhibition of Na,K-ATPase from NHK (A) and ADPKD (B) epithelial cells. Na,K-ATPase was determined in medium that contained 120 mM NaCl, 30 mM KCl, 3 mM MgCl 2 , 0.2 mM EGTA, 1 mM sodium azide, 30 mM Tris-HCl (pH 7.4), and 3 mM ATP, in the absence and presence of the indicated concentrations of ouabain. Na,K-ATPase activity was determined from the difference between the Na ϩ -and K ϩ -dependent hydrolysis of ATP in the absence or presence of the various ouabain concentrations. Data are expressed as percentage of the Na,K-ATPase activity in the absence of the inhibitor. Dose-response curves represent the best fit of the data assuming the presence of one (NHK) or two (ADPKD) Na,K-ATPase populations with different affinities for ouabain. The validity of the use of a two-component fit model for the ADPKD cells was corroborated using an F test, with P Ͻ 0.01. The inhibition constants (K i ) for each ouabain-sensitive enzyme population are shown. Each data point is the means Ϯ SE of the mean of quintuplicate determinations from three experiments that were performed in cells from two different kidneys.
The different magnitude in ouabain response that was reported for normal rat cells, compared with human cells, may just reflect differences between species.
Sensitivity of the Na,K-ATPase to ouabain is of critical importance in the response to the cardiotonic steroid (3, 4) . In contrast to NHK cells, ADPKD cells express a population of Na,K-ATPase that has an abnormally high affinity for ouabain.
The cause of the unique ouabain sensitivity phenotype of AD-PKD cells was not due to the aberrant expression of Na,KATPase isoforms, because only the ␣1␤1 isozyme was present in the cells. The ␣1 isoform expression that we observed agrees well with previous reports for normal and cystic human kidney (39) . Our results also confirm the expression of ␤1 in ADPKD. Although the potential for expression of the ␤2 subunit has been reported in human ADPKD kidneys (39), we were unable to detect it in the cultured cyst epithelial cells. It is well established that the binding sites for ouabain are located on the ␣ subunit, and the ␤ polypeptide does not influence the ouabain binding kinetics of the Na,K-ATPase (3, 36) . Therefore, it is clear that the change in proliferative response to ouabain in the ADPKD cells was not due to expression of ␣2, ␣3, ␣4, or the ␤ isoforms. It is interesting that we found that whereas ␥a and ␥b both are present in NHK and ADPKD cells, the ␥ polypeptides are upregulated in ADPKD cells. The ␥ subunit has been shown to be a regulator of Na,K-ATPase function that influences the kinetic properties of the enzyme (34). It is possible, then, that the increased ␥ polypeptide content of ADPKD cells may favor its interaction with the enzyme and, thereby, the response to ouabain. Additional explanations for the particular ouabain affinity of ADPKD cells include the expression of a yet-to-beidentified isoform of the Na,K-ATPase or mutations in the ␣1 polypeptide that render the enzyme more sensitive to ouabain. Alternatively, ouabain affinity may depend on interaction between the Na,K-ATPase and other proteins. The large intracellular region of the Na,K-ATPase between transmembrane domains 4 and 5 has been shown to interact with the C-terminus of polycystin 1 (40, 41) . It is interesting that we found that, in insect cells, exogenous expression of a construct that contains the transmembrane and C-terminal domains of polycystin 1 increases the sensitivity of the Na,K-ATPase to ouabain, with the enzyme exhibiting a K i for the steroid that is similar to that found in ADPKD cells (42) . Therefore, Na,K-ATPase-protein interaction represents another potential mechanism that is involved in the response of the cells to ouabain. Despite the mechanisms involved, ADPKD cells express a pool of the Na,KATPase that is more susceptible to bind and transmit the mitogenic signal of ouabain.
Activation of the mitogen-activated protein kinase (MAPK) pathway plays a primary role in proliferation of ADPKD cells. For example, EGF and TGF-␣ elicit mitogenic effect in ADPKD cells by the MEK-ERK pathway through binding to receptor tyrosine kinase (21) (22) (23) (24) , and cAMP promotes growth and secretion of ADPKD cells via B-Raf/MEK/ERK (21, 43) . Our results show that ouabain caused phosphorylation of ERK in ADPKD cells within 15 min of addition of the steroid, ERK phosphorylation was maximal at nanomolar ouabain concentrations, and inhibition of MEK blocked the effect. These results confirm the role of the MEK-ERK pathway in the mitogenic effect of ouabain and identify MEK and ERK as mediators of ouabain proliferation in ADPKD cells (15) . The kinetics of ERK phosphorylation and cell proliferation that were induced by ouabain are in good agreement. The relatively higher response in cell proliferation compared with P-ERK levels at 10 Ϫ10 M ouabain may reflect differences in the sensitivity of the exper- Figure 8 . Na,K-ATPase isoform expression in NHK and ADPKD cells. (A, C, and E) Total RNA that was isolated from NHK and ADPKD cells was subjected to reverse transcription, and the cDNA was amplified by PCR using oligonucleotides that are specific for each ␣ and ␤ isoforms and for the ␥ subunit of the Na,K-ATPase (see Table 1 ). Full-length cDNA for each subunit served as a control for specificity of the primers used. (B, D, and F) Immunoblot analysis of ␣ and ␤ isoforms and ␥ variants in NHK and ADPKD cells. Proteins from the various cell types were separated by SDS-PAGE, transferred to nitrocellulose, and subjected to immunoblot analysis. For the ␣1 isoform, the monoclonal 6F antibody was used. For ␣2, the MCB2 antibody, provided by K. Sweadner (Massachusetts General Hospital, Boston, MA), was used. The ␣3 and ␤1 isoforms were detected with mAb MA3-915 and M17-P5-F11, respectively (Affinity Bioreagents, Golden, CO). An anti-␣4 antiserum raised against the N-terminus of the protein was used to identify ␣4. For ␤2, an antiserum that was provided by P. Martin-Vasallo (Universidad de La Laguna, Tenerife, Spain) was used. For ␤3, a mAb from BD Biosciences (San Jose, CA) was used. For the ␥ subunits, a polyclonal antibody ␥969, provided by R. Mercer (Washington University, St. Louis, MO) was used. Expression of glyceraldehyde-3-phosphate dehydrogenase was determined, using a mAb from Abcam (Cambridge, MA). As a positive control for ␣1, ␣2, ␣3, ␤1, ␤2, and ␤3, human brain was used; for ␣4, human testis was used; and the ␥ control was produced in Sf-9 cells using baculoviruses.
imental methods used, or it may indicate that submaximal ERK activation may be sufficient to cause a prominent effect on ADPKD cell proliferation. Importantly, the ERK phosphorylation that was mediated by ouabain was observed not only in ADPKD cells that had not reached confluence (see Figures 2, 3 , 4, and 6) but also in confluent cell cultures (see Figure 5) , suggesting that the steroid also is capable of inducing growth of the cyst epithelium. A relatively lower ouabain-dependent ERK phosphorylation level was found in confluent compared with subconfluent cultures. We reason that the culture filter support limits ouabain accessibility to the basolateral side of the cells, where the Na,KATPase is localized. Alternatively, different from the subconfluent cultures, the tight monolayer that was established by ADPKD cells and the extensive formation of junctional complexes in the cultures may restrict the access of ouabain to the basolateral surface of the cells. In any case, both under subconfluent and confluent conditions, ADPKD cells exhibit a ouabain response that is not observed in NHK cells.
Importantly, ERK activation by ouabain in ADPKD cells is elicited only when the cardiotonic steroid is applied to the basal side of the culture. Our observation that Na,K-ATPase expression is limited to the basolateral membrane domain of the cells agrees with previous observations (28 -30) and with the notion that ouabain signal is transmitted through the Na,K-ATPase.
The effect of ouabain through its receptor, the Na,K-ATPase, resembles the nongenomic actions of other steroids. Strong evidence now supports the idea that steroids can bind to cell surface proteins to trigger downstream signaling cascades in the cell (44) . Rapid effects of estrogen and aldosterone via plasma membrane transport mechanisms, such as Ca 2ϩ -and voltage-activated K ϩ channels and the Na ϩ /H ϩ exchanger, have been reported (45, 46) . The effect of ouabain in ADPKD cells is consistent with that observed in several other cell types, in which ouabain binding to the Na,K-ATPase triggers ERK phosphorylation (15) . The presence of the lactone ring and sugar moieties in the steroidal structure of ouabain are important for specific binding to the Na,K-ATPase, the only known receptor to date for the compound (15, 47) . This, together with the presence of Na,K-ATPase high ouabain affinity sites and the restricted basolateral effect of ouabain that coincides with the localization of the enzyme in ADPKD cells, strongly supports that ouabain-dependent intracellular signaling in the cells occurs through the Na,K-ATPase. The effect of ouabain on proliferation of ADPKD cells takes place at nanomolar concentrations. These ouabain amounts correspond to the levels of ouabain reported in blood (8) . Therefore, under physiologic conditions, endogenous ouabain can readily activate the MEK-ERK pathway in the cyst cells of ADPKD kidneys, representing a factor that may have a direct impact on the growth of the cysts. A variety of circulating factors, hormones, and autocoids have been shown to stimulate the proliferation of renal cyst epithelial cells (21, 27, (23) (24) (25) 48, 49) . This study is the first to demonstrate that ouabain, an endogenous steroid hormone, has a positive effect on proliferation of ADPKD cells. Compounds that antagonize the action of ouabain are under development (50) and will represent an important tool for further understanding ouabain effect in AD-PKD and for an eventual clinical intervention of the disease.
Conclusion
We found that ADPKD cells express a population of Na,KATPase that has a high affinity for ouabain and respond to the steroid with an increase in proliferation that is mediated by the MEK-ERK pathway. The potential for endogenous ouabain as well as exogenous cardiotonic steroids to influence cyst mural cell growth is of clinical relevance for the progression of the disease.
